RecallDepth
Class II Terminated

Hydralazine HCL Tablets, USP, 50 mg in a single blister package, Rx only, Manufactured in Czech Republic by: Teva Czech Industries s.r.o. Opava-Komarov, Czech Republic, Distributed by Goldline Laboratories, Sellersville, PA, NDC 00182-0555-89 (carton) and 00182-0555-00 (single blister).

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 18, 2013
Posted
February 12, 2014
Recall Number
D-1075-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
112,800 tablets
Firm Location
Horsham, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.

Distribution

Nationwide

Lot / Code Info

Lot # 6A201018VA; Exp. 01/14.

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls